Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study

被引：1

作者：

Prete, Alessandra Anna

Manca, Paolo

Morano, Federica

Rasola, Cosimo

Messina, Marco

Formica, Vincenzo

Corsi, Domenico Cristiano

Cortesi, Enrico

Frassineti, Giovanni Luca

Zampino, M. Giulia

Casagrande, Mariaelena

Masi, Gianluca

Ronzoni, Monica

Scartozzi, Mario

Prisciandaro, Michele

Bergamo, Francesca

Vettore, Valentina

Pietrantonio, Filippo

Fassan, Matteo

Lonardi, Sara

机构：

[1] Veneto Inst Oncol IOV IRCCS, Dept Oncol Oncol 1, Padua, Italy

[2] Ist Nazl Tumori, Milan, Italy

[3] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, ENETS Ctr Excellence, Milan, Italy

[4] Univ Padua, Unit Surg Oncol & Gastroenterol, Padua, Italy

[5] UOC Oncol Fdn Ist G Giglio, Palermo, Italy

[6] Tor Vergata Univ, Med Oncol Unit, Rome, Italy

[7] Osped San Giovanni Calibita Fatebenefratelli, Med Oncol Unit, Rome, Italy

[8] Sapienza Univ Rome, Rome, Italy

[9] IRCCS, Med Oncol Unit, Ist Sci Romagnolo Studio Cura Tumori IRST, Meldola, Italy

[10] IRCCS, Ist Europeo Oncol, Div Oncol Med Gastrointestinale & Tumori Neurodoc, Milan, Italy

[11] Azienda Sanitaria Univ Integrata Udine, Dept Oncol, Udine, Italy

[12] Azienda Osped Univ Pisana, Pisa, Italy

[13] Ist Sci San Raffaele IRCSS, Dept Oncol, Milan, Italy

[14] Univ Hosp, Med Oncol Unit, Cagliari, Italy

[15] Univ Cagliari, Cagliari, Italy

[16] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy

[17] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy

[18] Univ Hosp Padua, Dept Pathol, Padua, Italy

[19] Veneto Inst Oncol IOV IRCCS, Padua, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期

关键词：

D O I：

10.1200/JCO.2022.40.4_suppl.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 50 条

[21] A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
Steven C. Plaxe
John A. Blessing
George Olt
Nader Husseinzadah
Samuel S. Lentz
Koen DeGeest
Fidel A. Valea
Cancer Chemotherapy and Pharmacology, 2002, 50 : 151 - 154
[22] A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study
Schilder, Russell J.
Sill, Michael W.
Lee, Yi-Chun
Mannel, Robert
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 929 - 933
[23] A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study
Plaxe, SC
Blessing, JA
Olt, G
Husseinzadah, N
Lentz, SS
DeGeest, K
Valea, FA
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 151 - 154
[24] Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix - A gynecologic oncology group study
Lincoln, S
Blessing, JA
McGehee, R
Lentz, SS
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (01): : 84 - 85
[25] Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial
de Vries, Hielke M.
Rafael, Tynisha S.
Gil-Jimenez, Alberto
de Feijter, Jeantine M.
Bekers, Elise
van der Laan, Elsbeth
Lopez-Yurda, Marta
Hooijberg, Erik
Broeks, Annegien
Peters, Dennis
Seignette, Iris M.
Pos, Floris J.
Horenblas, Simon
van Rhijn, Bas W. G.
Jordanova, Ekaterina S.
Brouwer, Oscar R.
Schaake, Eva
van der Heijden, Michiel S.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (31) : 4872 - +
[26] Phase 2 study of dalantercept in recurrent or metastatic squamous cell carcinoma of the head and neck
Jimeno, Antonio
Posner, Marshall R.
Weiss, Jared
Wirth, Lori J.
Saba, Nabil F.
Cohen, Roger B.
Popa, Elizabeta C.
Argiris, Athanassios
Grossmann, Kenneth F.
Sukari, Ammar
Korth, Chris
Wilson, Dawn
McClure, Ty
Alimzhanov, Marat
Pearsall, Scott
Attie, Kenneth M.
Sherman, Matthew L.
Pandya, Shuchi Sumant
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[27] EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial
Wittig, Andrea
Collette, Laurence
Appelman, Klaas
Buehrmann, Sandra
Jaeckel, Martin C.
Joeckel, Karl-Heinz
Schmid, Kurt Werner
Ortmann, Uta
Moss, Raymond
Sauerwein, Wolfgang A. G.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8B) : 1653 - 1665
[28] Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (XELOX-XRT) for squamous cell carcinoma of the anal canal
Eng, C.
Chang, G. J.
Das, P.
Rodriguez-Bigas, M.
Skibber, J. M.
Qiao, W.
Rosner, G. L.
Ukegbu, L. T.
Wolff, R. A.
Crane, C. H.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[29] Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Marabelle, Aurelien
Cassier, Philippe Alexandre
Fakih, Marwan
Guren, Tormod Kyrre
Italiano, Antoine
Kao, Steven Chuan-Hao
Nielsen, Dorte
Ascierto, Paolo Antonio
Bariani, Giovanni M.
Santoro, Armando
Shah, Manisha H.
Asselah, Jamil
El-Khoueiry, Anthony B.
Spencer, Kristen Renee
Takahashi, Shunji
Chatterjee, Arkendu
Jin, Fan
Norwood, Kevin
Delord, Jean-Pierre
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[30] PHASE-2 TRIAL OF ADRIAMYCIN AND CISDIAMMINEDICHLOROPLATINUM (CACP) IN ADVANCED SQUAMOUS-CELL CARCINOMA (SCC)
BONOMI, PD
MLADINEO, J
WILBANKS, GD
SLAYTON, R
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 311 - 311

← 1 2 3 4 5 →